• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Abdelaziz, H. (2021). QUALITY OF LIFE OF CHRONIC HEPATITIS C PATIENTS RECEIVING SOVALDI TREATMENT REGIMENAT SHARQ ALMADINA IN ALEXANDERIA. ALEXMED ePosters, 3(2), 72-73. doi: 10.21608/alexpo.2021.81938.1190
Hend Hassan Abdelaziz. "QUALITY OF LIFE OF CHRONIC HEPATITIS C PATIENTS RECEIVING SOVALDI TREATMENT REGIMENAT SHARQ ALMADINA IN ALEXANDERIA". ALEXMED ePosters, 3, 2, 2021, 72-73. doi: 10.21608/alexpo.2021.81938.1190
Abdelaziz, H. (2021). 'QUALITY OF LIFE OF CHRONIC HEPATITIS C PATIENTS RECEIVING SOVALDI TREATMENT REGIMENAT SHARQ ALMADINA IN ALEXANDERIA', ALEXMED ePosters, 3(2), pp. 72-73. doi: 10.21608/alexpo.2021.81938.1190
Abdelaziz, H. QUALITY OF LIFE OF CHRONIC HEPATITIS C PATIENTS RECEIVING SOVALDI TREATMENT REGIMENAT SHARQ ALMADINA IN ALEXANDERIA. ALEXMED ePosters, 2021; 3(2): 72-73. doi: 10.21608/alexpo.2021.81938.1190

QUALITY OF LIFE OF CHRONIC HEPATITIS C PATIENTS RECEIVING SOVALDI TREATMENT REGIMENAT SHARQ ALMADINA IN ALEXANDERIA

Article 140, Volume 3, Issue 2, June 2021, Page 72-73  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.81938.1190
View on SCiNiTO View on SCiNiTO
Author
Hend Hassan Abdelaziz email
Department of Community Medicine, Faculty of medicine, Alexanderia University, Egypt.
Abstract
Hepatitis C virus (HCV) infection is a worldwide public health problem, affecting about 3% of the world’s population.Nearly three quarters of infected individuals are living in middle income countries. China, Pakistan, Nigeria, Egypt, India, and Russia together accounted for more than half of total infections.

In response to the major problem of HCV in Egypt, the Egyptian Ministry of Health and Population (MOHP) launched the National Committee for Control of Viral Hepatitis. The introduction of sofosbuvir (Sovaldi) markedly changed therapeutic outcomes.
Health Related Quality of Life (HRQoL) has become a frequent and valuable outcome measure in clinical research with patients facing chronic diseases, including chronic liver diseases. The assessment of HRQoL in HCV patients under treatment might help to better understand the effect of treatment on the patient’squality of life. It can influence the decision -making process during therapeutic management of the patients.
Aim of the work
The study was conducted to assess quality of life of chronic hepatitis C patients receiving Sovaldi containing regimen atoutpatient hepatology clinic in Sharq Al-madina hospital and identify factors associated with it.
Keywords
HCV; SOVALDI; QUALITY OF LIFE
Supplementary Files
download 0072-1190 Hend Hassan Abdelaziz.pdf
Statistics
Article View: 125
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.